Home - Products - Angiogenesis - VEGFR - Jaceidin

Jaceidin

CAS No. 10173-01-0

Jaceidin( Jaceidine | Quercetagetin 3,3',6-trimethyl ether | 5,7,4'-Trihydroxy-3,6,3'-trimethoxyflavone )

Catalog No. M29313 CAS No. 10173-01-0

Jaceidin is a membrane-permeable inhibitor of VEGFR with anti-tumor activities.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Jaceidin
Note

Research use only, not for human use.
Brief Description

Jaceidin is a membrane-permeable inhibitor of VEGFR with anti-tumor activities.
Description

Jaceidin is a membrane-permeable inhibitor of VEGFR with anti-tumor activities.(In Vitro):Jaceidin shows antiplatelet activity and modest antioxidant activity in a dose-dependent manner.
In Vitro

——
In Vivo

——
Synonyms

Jaceidine | Quercetagetin 3,3',6-trimethyl ether | 5,7,4'-Trihydroxy-3,6,3'-trimethoxyflavone
Pathway

Angiogenesis
Target

VEGFR
Recptor

VEGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

10173-01-0
Formula Weight

360.31
Molecular Formula

C18H16O8
Purity

>98% (HPLC)
Solubility

——
SMILES

COc1cc(ccc1O)-c1oc2cc(O)c(OC)c(O)c2c(=O)c1OC
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Ranibizumab

Ranibizumab is an antibody fragment without the Fc portion and affinity-matured to more strongly bind VEGF-A.
Acrizanib

Acrizanib (LHA510, LHA-510) is a novel potent, selective VEGFR-2 (KDR) inhibitor with IC50 of 17.4 nM in cell-based assays.
SU14813 maleate

A broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.

Sign In Join Free